The advent of fair treatment allocation schedules in clinical trials during the 19th and early 20th centuries

Journal of the Royal Society of Medicine

Volumn 105, Issue 5, 2012, Pages 221-227

  Chalmers, Iain ^a   Dukan, Estela ^b   Podolsky, Scott ^c   Smith, George Davey ^d  

^a Summertown Pavilion   (United Kingdom)

^b ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH   (United Kingdom)

^c Center for the History of Medicine   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); HUMAN; FEMALE; HEALTH CARE DELIVERY; HISTORY; MALE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD; UNITED KINGDOM;

DELIVERY OF HEALTH CARE; FEMALE; GREAT BRITAIN; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MALE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84864779054     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.2012.12k029     Document Type: Article

References (62)

1. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. BMJ 1948, 2, 769-82
2. Chalmers I. Statistical theory was not the reason that randomisation was used in the British Medical Research Council's clinical trial of streptomycin for pulmonary tuberculosis. In, Jorland G, Opinel A, Weisz G, eds. Body counts, medical quantification in historical and sociological perspectives. Montreal, McGill-Queens University Press, 2005, 309-34
3. Chalmers I. Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers. JLL Bulletin, Commentaries on the history of treatment evaluation, 2010 (www.jameslindlibrary.org)
4. Cox DR. Randomization for concealment. JLL Bulletin, Commentaries on the history of treatment evaluation, 2009 (www.jameslindlibrary.org)
5. Tröhler U. The introduction of numerical methods to assess the effects of medical interventions during the [18th] century, a brief history. JLL Bulletin, commentaries on the history of treatment evaluation, 2010a (www.jameslindlibrary.org)
6. Kaptchuk TJ. A brief history of the evolution of methods to control of observer biases in tests of treatments. JLL Bulletin, Commentaries on the history of treatment evaluation, 2011 (www.jameslindlibrary.org)
7. Huth EJ. Jules Gavarret's Principes Généraux de Statistique Médicale, a pioneering text on the statistical analysis of the results of treatments. JLL Bulletin, Commentaries on the history of treatment evaluation, 2006a (www. jameslindlibrary.org)
8. al-Razi (10th century CE, 4th Century AH). Kitab al-Hawi fi al-tibb. [The comprehensive book of medicine]
9. Tibi S. Al-Razi and Islamic medicine in the 9th Century. JLL Bulletin, Commentaries on the history of treatment evaluation, 2005 (www.jameslindlibrary.org)
10. Petrarch F. Rerum Senilium Libri. Liber XIV, Epistola Letter to Boccaccio (V.3), 1364. [Letters of old age.]
11. Massey I. A short and plain account of inoculation. With some remarks on the main argument made use of to recommend that practice, by Mr. Maitland and others. To which is added, a letter to the learned James Jurin, M. D.R.S. Secr. Col. Reg. Med. Lond. Soc. London, W. Meadows, 1723
12. Lind J. A treatise of the scurvy. In three parts. Containing an inquiry into the nature, causes and cure, of that disease. Together with a critical and chronological view of what has been published on the subject. Edinburgh, Printed by Sands, Murray and Cochran for A Kincaid and A Donaldson, 1753
13. Silverman WA, Chalmers I. Casting and drawing lots, a time-honoured way of dealing with uncertainty and for ensuring fairness. JLL Bulletin, Commentaries on the history of treatment evaluation, 2002 (www. jameslindlibrary.org)
14. Van Helmont JB. Ortus medicinæ, Id est Initia physicæ inaudita. Progressus medicinae novus, in morborum ultionem, ad vitam longam. [The dawn of medicine, That is, the beginning of a new Physic. A new advance in medicine, a victory over disease, to [promote] a long life Amsterodami, Apud Ludovicum Elzevirium, 1648, 526-7
15. Starkey G. Natures explication and Helmont's vindication...Or A short and sure way to a long and sound life. London, printed by E. Cotes for Thomas Alsop at the two Sugar-loaves over against St. Antholins Church at the lower end of Watling Street, 1658
16. Mesmer FA. Précis historique des faits relatifs au magnétisme animal jusques en avril 1781. Par M. Mesmer, Docteur en Médecine de la Faculté de Vienne. Ouvrage traduit de l'Allemand. [Historical account of facts relating to animal magnetism up to April 1781. By M. Mesmer, Doctor in Medicine of the Vienna Faculty. Work translated from German] A Londres [false imprint, probably Paris.], 1781, 111-4, 182
17. Hamilton AL. Dissertatio Medica Inauguralis De Synocho Castrensi (Inaugural medical dissertation on camp fever). Edinburgh, J Ballantyne, 1816
18. Milne I, Chalmers I. Hamilton's report of a controlled trial of bloodletting, 1816. JLL Bulletin, Commentaries on the history of treatment evaluation, 2002 (www. jameslindlibrary.org)
19. Löhner G, on behalf of a society of truth-loving men. Die homöopathischen Kochsalzversuche zu Nü rnberg [The homeopathic salt trials in Nuremberg]. Nuremberg, 1835
20. Stolberg M. Inventing the randomized double-blind trial, The Nuremberg salt test of 1835. JLL Bulletin, Commentaries on the history of treatment evaluation, 2006 (www.jameslindlibrary.org)
21. Balfour TG. Quoted in West C. Lectures on the Diseases of Infancy and Childhood. London, Longman, Brown, Green and Longmans, 1854, 600
22. Chalmers I, Toth B. 19th century controlled trials to test whether belladonna prevents scarlet fever. JLL Bulletin, Commentaries on the history of treatment evaluation, 2009 (www.jameslindlibrary.org)
23. Pasteur L. Compte rendu sommaire des expériences rates á Pouilly-le-Fort, prés Melun, sur la vaccination charbonneuse. Comptes rendus de l'Académie des Sciences 1881, 92, 1378-83
24. Gavarret LDJ. Principes généraux de statistique médicale, ou développement des regles qui doivent présider a son emploi. Paris, Bechet jeune & Labé, 1840
25. Bartlett E. An essay on the philosophy of medical science. Philadelphia, Lea and Blanchard, 1844
26. Huth EJ. Transatlantic ideas on the philosophy of therapeutics in the middle of the 19th century. JLL Bulletin, Commentaries on the history of treatment evaluation, [2006b] (www.jameslindlibrary.org)
27. GuyWA. Croonian Lectures on the numerical method, and its application to the science and art of medicine. BMJ 1860, 2, 553-5
28. Ephraim A. Uber die Bedeutung de statistischen Methode fü r die Medicin. [On the relevance of the statistical method for medicine] Volkmann's Sammlung Klinische Vortraege N.F. Innere Medicin (1890-1894), 24, 706-16. Leipzig, Breitkopf and Härtel
29. Wanscher O. Om Diphteritis og Croup-særligt med hensyn til Tracheostomien ved samme. [On diphtheria and croup-especially regarding tracheostomy in this condition]. Disputats [Thesis]. Jacob Lund, Kjøbenhavn, 1877, 67-8
30. Polverini G. Serumtherapie gegen Beulenpest [Serum treatment of bubonic plague]. Muenchener Med. Wochenschrift 1903, 50, 649-51
31. Choksy KBNH. On recent progress in serum-therapy of plague. BMJ 1908, 1, 1282-4
32. Cousin M. Des éruptions consécutives aux injections de sérum antidiphthérique et de leur traitement prophylactique par l'ingestion de clorure de calcium. These pour le Doctorat en médicine. Paris, Jules Rousset, 1905, 36-44
33. Netter A. Efficacité de l'ingestion de chlorure de calcium comme moyen préventif des éruptions consecutives aux injections de sérum. Séances et Mémoires de la Société de Biologie 1906, 58, 279-80
34. Bullowa JGM. The use of antipneumococcic refined serum in lobar pneumonia, data necessary for a comparison between cases treated with serum and cases not so treated, and the importance of a significant control series of cases. JAMA 1928, 90, 1354-58
35. Cecil RL, Plummer N. Pneumococcus Type I pneumonia-a study of eleven hundred and sixty-one cases, with especial reference to specific therapy. JAMA 1930, 95, 1547-53
36. Wagner-Jauregg J. Ueber die Infektionsbehandlung der progressiven Paralyse [On infection treatment of progressive paralysis]. Münchener Medizinische Wochenschrift 1931, 78, 4-7
37. Fisher RA. The design of experiments. Edinburgh, Oliver and Boyd, 1935
38. Doull JA, Hardy M, Clark JH, Herman NB. The effect of irradiation with ultra-violet light on the frequency of attacks of upper respiratory disease (common colds). American Journal of Hygiene 1931, 13, 460-77
39. Theobald GW. Effect of calcium and vitamin A and D on incidence of pregnancy toxaemia. Lancet 1937, 2, 1397-99
40. Bell JG. Pertussis prophylaxis with two doses of alum-precipitated vaccine. Public Health Reports 1941, 56, 1535-46
41. Armitage P. Randomisation and alternation, a note on Diehl et al. JLL Bulletin, commentaries on the history of treatment evaluation, 2002 (www.jameslindlibrary.org)
42. Hill AB. Principles of medical statistics. London, Lancet, 1937
43. Ramanna M. Commentary, NH Choksy and serum therapy. Int J Epidemiol Home Contents, 2011
44. Syed IS, Swaminathan KL. Commentary, Dr. Choksy's dilemma. Int J Epidemiol, 2011 doi, 10.1093/ije/dyr168
45. Chakrabarti P. Commentary, An experimental theatre for vaccines, Bombay in the time of plague. Int J Epidemiol, 2011
46. Davey-Smith G. Int J Epidemiol, 2011
47. Podolsky SH. Jesse Bullowa, specific treatment for pneumonia, and the development of the controlled clinical trial. JLL Bulletin, Commentaries on the history of treatment evaluation, 2008 (www.jameslindlibrary.org)
48. Bryder L. The Medical Research Council and clinical trial methodologies before the 1940s, the failure to develop a 'scientific' approach. JLL Bulletin, Commentaries on the history of treatment evaluation, 2010 (www. jameslindlibrary.org)
49. Middleton DS. Tea for burns or scalds in the home. BMJ 1936, 1, 555
50. Heiberg P. Studier over den statistiske undersøgelsesmetode som hjælpemiddel ved terapeutiske undersøgelser [Studies on the statistical study design as an aid in therapeutic trials]. Bibliotek for Læger 1897, 89, 1-40
51. Wright AE, Morgan WP, Colebrook L, Dodgson RW. Observations on prophylactic inoculation against pneumococcus infections, And on the results which have been achieved by it. Lancet 1914, 1, 87-95
52. Sollmann T. The crucial test of therapeutic evidence. JAMA 1917, 69, 198-9
53. Bingel A. Ü ber Behandlung der Diphtherie mit gewöhnlichem Pferdeserum. Deutsches Archiv fü r Klinische Medizin 1918, 125, 284-332
54. Tröhler U. Adolf Bingel's blinded, controlled comparison of different anti-diphtheritic sera in 1918. JLL Bulletin, Commentaries on the history of treatment evaluation, [2010b] (www.jameslindlibrary.org)
55. Opinel A, Tröhler U, Gluud C, Gachelin G, Davey Smith G, Podolsky S, Chalmers I. The evolution of methods to assess the effects of treatments, illustrated by the development of treatments for diphtheria, 1825-1918. Int J Epidemiol, 2011 doi, 10.1093/ije/dyr162
56. Advisory Committee on Plague Investigations in India. The serum treatment of human plague. Journal of Hygiene. Plague Supplement II, 1912, LVI, 326-39
57. Podolsky SH. Pneumonia before antibiotics, therapeutic evolution and evaluation in twentieth-century America. Baltimore, Johns Hopkins University Press, 2006
58. Medical Research Council Therapeutic Trials Committee. The serum treatment of lobar pneumonia. BMJ 1934, 1, 241-5
59. Hill AB. Serum treatment of pneumonia, 22 December [1933,] cited in Austoker J, Bryder L, eds. Historical perspectives on the role of the MRC. Oxford, Oxford University Press 1989, 1933, 46-7
60. Medical Research Council. Clinical trial of patulin in the common cold. Lancet 1944, 2, 373-5
61. Chalmers I, Clarke M. The 1944 Patulin Trial, the first properly controlled multicentre trial conducted under the aegis of the British Medical Research Council. International Journal of Epidemiology 2004, 32, 253-60
62. Doll R. The role of data monitoring committees. In, Duley L, Farrell B, eds. Clinical Trials. London, BMJ Books, 2002, 97-104